Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Topic Home
bullet Programs
bullet Offices
bullet Disease Listing
Quick Links
Get Smart on the Farm
11 Aug 2005
CDC Foundation interview with Tom Chiller, epidemiologist and medical director of CDC's Get Smart on the Farm program.
Contact Info

1600 Clifton Road NE, MS-D63
Atlanta, GA 30033
Phone: + 1-800-311-3435

Email Us

 
Division of Bacterial and Mycotic Diseases

Legionellosis:
Legionnaires' Disease (LD) and Pontiac Fever


Clinical Features Legionnaires' disease, (LD), is the more severe form of legionellosis and is characterized by pneumonia, commencing 2-10 days after exposure. Pontiac fever is an acute-onset, flu-like, non-pneumonic illness, occuring within a few hours to two days of exposure.
Etiologic Agent Legionella pneumophila and other Legionella species. At least 46 species and 70 serogroups have been identified. L.pneumophila, an ubiquitous aquatic organism that thrives in warm environments (32°- 45°C) causes over 90% of LD in the United States.
Incidence An estimated 8,000-18,000 cases occur each year in the United States, but only a fraction of these are reported. Most LD cases are sporadic; 23% are nosocomial and 10%-20% can be linked to outbreaks. Pontiac fever has been recognized only during outbreaks.
Sequelae Death occurs in 10%-15% of LD cases: a substantially higher proportion of fatal cases occur during nosocomial outbreaks. Pontiac fever is a self-limited disease that requires no treatment.
Transmission Inhalation of contaminated aerosols from devices such as cooling towers, showers, and faucets, and aspiration of contaminated water. Person-to-person transmission does not occur.
Risk Groups The elderly, cigarette smokers, persons with chronic lung or immunocompromising disease, and persons receiving immunosuppressive drugs.
Surveillance LD is a reportable condition in most states; because of under-diagnosis and underreporting, however, only 2%-10% of estimated cases are reported.
Trends Increasing awareness among physicians and use of more sensitive, noninvasive tests such as urine antigen testing has led to improved recognition of sporadic cases and outbreaks caused by L. pneumophila, serogroup 1. Decreased use of culturing may be hampering recognition of infections caused by Legionella species and serogroups.
Challenges Diagnosis of legionellosis requires specialized testing. Optimal methods for prevention of legionellosis are not known, and source of most sporadic cases is unknown. Rapid detection of travel-related legionellosis is needed to identify potentially preventable disease transmission.
Opportunities Tests with improved sensitivity have been developed but more are needed. Improved understanding of ecology of Legionella can increase the effectiveness of prevention and control measures.
 
 
Date: October 12, 2005
Content source: Coordinating Center for Infectious Diseases / Division of Bacterial and Mycotic Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435